An observational study in Endometrial Cancer, sponsored by Aristotle University Of Thessaloniki. Active, not recruiting at 1 site in Greece. Open to female participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-09-19.
Sponsored by Aristotle University Of Thessaloniki · Observational
Molecular classification that has been recently incorporated in FIGO classification of endometrial cancer is a new triage tool for the better management of endometrial cancer patients.
1,325 studies on the registry are indexed under Endometrial Neoplasms; 447 are open to participants now.
This study's planned enrollment of 80 is below the median of 179 across 321 observational studies indexed under Endometrial Neoplasms.
Browse Endometrial Neoplasms studies →Aristotle University Of Thessaloniki is the lead sponsor of 274 studies on the registry; 56 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Endometrial cancer patients that underwent surgery and were tested for molecular analysis (POLE, MSI, p53)
Exclusion Criteria:
Multidisciplinary Team Board decision change
MDT decision for adjuvant treatment (Rate of adjuvant treatment change)
Time frame: 2 years (study completion)
Plan to share: No
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Aristotle University Of Thessaloniki